Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer

Samankaltaisia teoksia

• Investigation of the effect of the farnesyl protein transferase inhibitor R115777 on isoprenylation and intracellular signalling by the prostacyclin receptor
  Tekijä: O'Meara, Sarah J, et al.
  Julkaistu: (2004)
• Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor
  Tekijä: Sparreboom, A, et al.
  Julkaistu: (2004)
• Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways
  Tekijä: Dalenc, Florence, et al.
  Julkaistu: (2005)
• Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411
  Tekijä: Crane, Christopher H., et al.
  Julkaistu: (2009)
• The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase
  Tekijä: Marcus, Adam I., et al.
  Julkaistu: (2005)